Smart testing for smart drugs
04 January 2010Can better decisions be made about which anticancer drugs to progress to clinical trials?
Research sheds new light on why pancreatic cancer drugs fail
21 May 2009An international team of scientists, led by researchers based at the Cambridge Research Institute, have discovered a new mechanism that may explain why pancreatic cancer patients are often resistant to a common chemotherapy treatment, germcitabine.
CRI: linking the laboratory to the cancer clinic
01 May 2009The Cambridge Research Institute (CRI) is driving the development of new approaches for the early detection, prevention and treatment of cancer.
